Hans Jasper Genee

Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.

Livingston International, Inc. engages in provision of customs brokerage, transportation and integrated logistics services. Its services include customs brokerage, U.S. customs brokerage, Canadian customs brokerage, Mexican customs brokerage, freight and transportation, global trade management, trade consulting, trade technology, business process services, trade sphere and vehicle transportation services. The company was founded by Gerry Livingston in 1945 and is headquartered in Toronto, Canada.

Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

iNovia Capital, Inc., formerly MSBi Capital, is a venture capital firm founded in 2001 by Shawn Abbott. The firm is headquarters in Montreal Canada.

EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark.

Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark.

Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark.

ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.

Danske Spil A/S provides lotteries and gambling services. The company was founded on July 21, 1948 and is headquartered in Brondby, Denmark.

Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark.

Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.

Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom.

Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland.

SNIPR Biome ApS develops bacterial composition to provide treatment for diabetes to cancer. The company was founded by Christian Grøndal and is headquartered in Kongens Lyngby, Denmark.

NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.

DMC Biotechnologies, Inc. operates as an early-stage biotechnology company. The firm is the low cost sustainable transformation of multiple product markets. The company was founded by Matt Lipscomb and Mike Lynch in August 2014 and is headquartered in Boulder, CO.

Mycoworks, Inc. engages in producing leather from mycelium materials. The company was founded by Sophia Wang, Philip Ross and Eddie Pavlu and is headquartered in San Jose, CA.

BioPhero ApS provides bio-based pheromones for pest management. The company was founded by Irina Borodina and Carina Holkenbrink and is headquartered in Kongens Lyngby, Denmark.

Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections.

Union Therapeutics A/S operates as a clinical stage pharmaceutical company which focuses on the treatment of inflammatory skin disease. It also centers in the development of molecules exhibiting immunological and microbiological effects. The company is headquartered in Hellerup, Denmark.

Bactolife A/S is a Danish industrial biotech company that specializes in developing biological solutions to strengthen the gut microbiome and combat antimicrobial resistance. Bactolife is based in Kongens Lyngby, Denmark and was founded in 2017 by Andreas Hougaard Laustsen, Per Falholt, Mads Laustsen, David Kauffmann, and Sandra Wingaard Thrane. The company has approximately 40 employees and uses its proprietary binding protein technology to select and produce binding proteins that act on toxins without targeting growth or killing bacteria directly. Bactolife is developing and marketing ingredients for various groups, including mothers and children, the elderly, immunodeficient individuals, travelers, deployed individuals, and animal health. The company has proof of concept for its technology, including its most advanced animal health product, ablacto+, which stabilizes the gut of piglets and reduces the severity of post-weaning diarrhea. Mads Laustsen has been the CEO since 2017.

The Protein Brewery BV operates as a agricultural and industrial biotechnology company. It develops proprietary technologies in the field of non-animal food production and organic crop farming. Its products include Fermotein, an ingredient for meat substitutes, processed meats, bread, protein bars, and bakery products. The company was founded by Wim de Laat in 2010 and is headquartered in Breda, the Netherlands.

Clinical-Microbiomics A/S is a Danish private company located in Copenhagen with domestic subsidiaries. The firm engages in conducting biotechnology research and experimental development. Anders Grøn is currently the CEO of the company.

Part of Ejendomsselskabet Hvidovre Torv Holding AS, Ejendomsselskabet Hvidovre Torv AS engages in rental of commercial real estate properties. The company is based in Aarhus, Denmark.

VenomAid Diagnostics ApS provides diagnostic test services for snake bites. The company is based in Kongens Lyngby, Denmark. The Danish company was founded by Cecilie Knudsen, Søren H. Dam, Jonas A. Jürgensen, Andreas Hougaard Laustsen. Jonas A. Jürgensen has been the CEO since incorporation.

Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark.

Advanced MR Analytics AB offers solutions for body composition analysis. It transforms subjective magnetic resonance images into fat and muscle measurements. The firm provides technical research such as data acquisition and reconstruction; registration and fusion; machine learning and signal representation; modelling and simulation; simulation, classification, and quantification; visualization and image enhancement; and user interfaces and interaction. The company was founded by David Magnus Borga and Olof Erik Gunnar Dahlqvist Leinhard in 2010 and is headquartered in Link?ping, Sweden.